629 related articles for article (PubMed ID: 29630898)
1. Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.
Sethi V; Kurtom S; Tarique M; Lavania S; Malchiodi Z; Hellmund L; Zhang L; Sharma U; Giri B; Garg B; Ferrantella A; Vickers SM; Banerjee S; Dawra R; Roy S; Ramakrishnan S; Saluja A; Dudeja V
Gastroenterology; 2018 Jul; 155(1):33-37.e6. PubMed ID: 29630898
[TBL] [Abstract][Full Text] [Related]
2. Antibiotics-induced gut microbiota dysbiosis promotes tumor initiation via affecting APC-Th1 development in mice.
Xu C; Ruan B; Jiang Y; Xue T; Wang Z; Lu H; Wei M; Wang S; Ye Z; Zhai D; Wang L; Lu Z
Biochem Biophys Res Commun; 2017 Jun; 488(2):418-424. PubMed ID: 28506830
[TBL] [Abstract][Full Text] [Related]
3. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells.
Benakis C; Brea D; Caballero S; Faraco G; Moore J; Murphy M; Sita G; Racchumi G; Ling L; Pamer EG; Iadecola C; Anrather J
Nat Med; 2016 May; 22(5):516-23. PubMed ID: 27019327
[TBL] [Abstract][Full Text] [Related]
4. Beneficial Effect of Antibiotics and Microbial Metabolites on Expanded Vδ2Vγ9 T Cells in Hepatocellular Carcinoma Immunotherapy.
Han J; Zhang S; Xu Y; Pang Y; Zhang X; Hu Y; Chen H; Chen W; Zhang J; He W
Front Immunol; 2020; 11():1380. PubMed ID: 32849498
[TBL] [Abstract][Full Text] [Related]
5. Host dysbiosis negatively impacts IL-9-producing T-cell differentiation and antitumour immunity.
Almeida RR; Vieira RS; Castoldi A; Terra FF; Melo ACL; Canesso MCC; Lemos L; Cipelli M; Rana N; Hiyane MI; Pearce EL; Martins FDS; Faria AMC; Câmara NOS
Br J Cancer; 2020 Aug; 123(4):534-541. PubMed ID: 32499569
[TBL] [Abstract][Full Text] [Related]
6. IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice.
Song Q; Wang X; Wu X; Kang TH; Qin H; Zhao D; Jenq RR; van den Brink MRM; Riggs AD; Martin PJ; Chen YZ; Zeng D
Nat Commun; 2021 Feb; 12(1):805. PubMed ID: 33547295
[TBL] [Abstract][Full Text] [Related]
7. Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.
Purwar R; Schlapbach C; Xiao S; Kang HS; Elyaman W; Jiang X; Jetten AM; Khoury SJ; Fuhlbrigge RC; Kuchroo VK; Clark RA; Kupper TS
Nat Med; 2012 Aug; 18(8):1248-53. PubMed ID: 22772464
[TBL] [Abstract][Full Text] [Related]
8. Depletion of Intestinal Microbiome Partially Rescues Bone Loss in Sickle Cell Disease Male Mice.
Tavakoli S; Xiao L
Sci Rep; 2019 Jun; 9(1):8659. PubMed ID: 31209247
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of gut microbiota induced the disorder of helper T cells in influenza virus-infected mice.
Yu B; Dai CQ; Chen J; Deng L; Wu XL; Wu S; Zhao CL; Jiang ZY; Chen XY
Hum Vaccin Immunother; 2015; 11(5):1140-6. PubMed ID: 25874358
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking.
Jenkins SV; Robeson MS; Griffin RJ; Quick CM; Siegel ER; Cannon MJ; Vang KB; Dings RPM
Cancer Res; 2019 Dec; 79(23):5999-6009. PubMed ID: 31591154
[TBL] [Abstract][Full Text] [Related]
11. The microbiome and hepatobiliary-pancreatic cancers.
Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
[TBL] [Abstract][Full Text] [Related]
12. Inhibition effect of glycyrrhiza polysaccharide (GCP) on tumor growth through regulation of the gut microbiota composition.
Zhang X; Zhao S; Song X; Jia J; Zhang Z; Zhou H; Fu H; Cui H; Hu S; Fang M; Liu X; Bian Y
J Pharmacol Sci; 2018 Aug; 137(4):324-332. PubMed ID: 30150145
[TBL] [Abstract][Full Text] [Related]
13. The Local Defender and Functional Mediator: Gut Microbiome.
Yang H; Duan Z
Digestion; 2018; 97(2):137-145. PubMed ID: 29310114
[TBL] [Abstract][Full Text] [Related]
14. Human Mucosa-Associated Invariant T Cells Accumulate in Colon Adenocarcinomas but Produce Reduced Amounts of IFN-γ.
Sundström P; Ahlmanner F; Akéus P; Sundquist M; Alsén S; Yrlid U; Börjesson L; Sjöling Å; Gustavsson B; Wong SB; Quiding-Järbrink M
J Immunol; 2015 Oct; 195(7):3472-81. PubMed ID: 26297765
[TBL] [Abstract][Full Text] [Related]
15. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.
Sivan A; Corrales L; Hubert N; Williams JB; Aquino-Michaels K; Earley ZM; Benyamin FW; Lei YM; Jabri B; Alegre ML; Chang EB; Gajewski TF
Science; 2015 Nov; 350(6264):1084-9. PubMed ID: 26541606
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
[TBL] [Abstract][Full Text] [Related]
17. The microbiota in adaptive immune homeostasis and disease.
Honda K; Littman DR
Nature; 2016 Jul; 535(7610):75-84. PubMed ID: 27383982
[TBL] [Abstract][Full Text] [Related]
18. Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine.
Maeda Y; Kurakawa T; Umemoto E; Motooka D; Ito Y; Gotoh K; Hirota K; Matsushita M; Furuta Y; Narazaki M; Sakaguchi N; Kayama H; Nakamura S; Iida T; Saeki Y; Kumanogoh A; Sakaguchi S; Takeda K
Arthritis Rheumatol; 2016 Nov; 68(11):2646-2661. PubMed ID: 27333153
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.
Uribe-Herranz M; Bittinger K; Rafail S; Guedan S; Pierini S; Tanes C; Ganetsky A; Morgan MA; Gill S; Tanyi JL; Bushman FD; June CH; Facciabene A
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467322
[TBL] [Abstract][Full Text] [Related]
20. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.
Ray A; Dittel BN
Immunology; 2015 Nov; 146(3):359-68. PubMed ID: 26211540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
